A Phase I Single Center Study to Evalute the Safety, Tolerability and Pharmacokinetics of Intravenous IdeS After Administration of Single Ascending Doses in Healthy Male Subjects.

Trial Profile

A Phase I Single Center Study to Evalute the Safety, Tolerability and Pharmacokinetics of Intravenous IdeS After Administration of Single Ascending Doses in Healthy Male Subjects.

Completed
Phase of Trial: Phase I

Latest Information Update: 24 Jan 2017

At a glance

  • Drugs IdeS (Primary)
  • Indications Transplant rejection
  • Focus Adverse reactions; First in man; Proof of concept
  • Sponsors Hansa Medical AB
  • Most Recent Events

    • 16 Jul 2015 According to Hansa Medical AB media release, results have been published in PLOS ONE.
    • 16 Jul 2015 Results published in Hansa Medical AB media release.
    • 18 Feb 2015 Results published in Hansa Medical AB media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top